Proposed is a longitudinal cross-site comparison study of syringe exchange program (SEP) operational characteristics and changes in individual HIV risk behaviors among injection drug users (IDUs). The overall aim is to determine how differences in SEP operational characteristics may impact changes in HIV risk behavior among SEP clients. Recent reviews of SEP studies suggest that inattention to SEP operational characteristics have biased interpretations of program effectiveness. Yet, few SEP studies provide program information such as syringe distribution protocols and availability of ancillary services. This lack of detail is particularly problematic since SEPs must set policies related to syringe distribution protocol, limits on syringes, and availability of complementary ancillary services without benefit of empirical data on the impact of these choices. To address this problem we propose the following specific aims: (1) To compare changes in HIV risk behaviors among IDUs who use SEPs with different syringe distribution protocols, (2) To compare changes in HIV risk behaviors among IDUs who use a SEP with a limit on the number of syringes that can be exchanged with IDUs who use an SEP with no such limit, and (3), To compare changes in HIV risk behaviors and utilization of medical, social, and substance use services among IDUs who use an SEP that provides complementary ancillary medical services as compared to IDUs who use a SEP without such ancillary services. To accomplish these aims, we will compare SEP client risk behaviors at SEPs with the following operational characteristics: la) one-for-one exchange versus one-for-one plus extra syringes; lb) one-for-one exchange versus need-based distribution, lc) one-for-one plus extra syringes versus need-based distribution; 2) limits on number of syringes exchanged per visit versus no limits on syringes exchanged; and 3) availability of complementary ancillary services (e.g. HIV screening and medical provider, including nurses and/or physician assistant) at SEP sites versus no ancillary services. Each of the 5 selected SEPs is matched to another program on two of the three operational variables of interest, thus permitting comparisons on the third variable. 1,500 IDUs (750 SEP clients; 750 non-SEP using IDUs) will be recruited, interviewed, and followed for 6 months in three waves of data collection beginning in Year 01 and ending in Year 05 from these SEPs and their catchment areas.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA014210-03
Application #
6754361
Study Section
Special Emphasis Panel (ZRG1-AARR-7 (01))
Program Officer
Jones, Dionne
Project Start
2002-09-30
Project End
2006-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
3
Fiscal Year
2004
Total Cost
$656,847
Indirect Cost
Name
Rand Corporation
Department
Type
DUNS #
006914071
City
Santa Monica
State
CA
Country
United States
Zip Code
90401
Fink, David S; Lindsay, Suzanne P; Slymen, Donald J et al. (2013) Abscess and self-treatment among injection drug users at four California syringe exchanges and their surrounding communities. Subst Use Misuse 48:523-31
Martinez, Alexis N; Bluthenthal, Ricky N; Flynn, Neil M et al. (2011) HIV risks and seroprevalence among Mexican American injection drug users in California. AIDS Behav 15:95-102
Martinez, Alexis N; Bluthenthal, Ricky N; Neilands, Torsten et al. (2011) Assessing geographic and individual level factors associated with arrests among injection drug users in California. Health Place 17:1258-65
Kral, Alex H; Lorvick, Jennifer; Martinez, Alexis et al. (2011) HIV prevalence and risk among heterosexual methamphetamine injectors in California. Subst Use Misuse 46:1081-9
Wagner, Karla Dawn; Unger, Jennifer B; Bluthenthal, Ricky N et al. (2010) Cognitive behavioral theories used to explain injection risk behavior among injection drug users: a review and suggestions for the integration of cognitive and environmental models. Health Educ Behav 37:504-32
Bluthenthal, Ricky; Kral, Alex (2010) Commentary on Palmateer et al. (2010): next steps in the global research agenda on syringe access for injection drug users. Addiction 105:860-1
Bluthenthal, Ricky N; Heinzerling, Keith G; Anderson, Rachel et al. (2008) Approval of syringe exchange programs in California: results from a local approach to HIV prevention. Am J Public Health 98:278-83
Bluthenthal, Ricky N; Anderson, Rachel; Flynn, Neil M et al. (2007) Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend 89:214-22
Sharma, Mukta; Burrows, Dave; Bluthenthal, Ricky (2007) Coverage of HIV prevention programmes for injection drug users: confusions, aspirations, definitions and ways forward. Int J Drug Policy 18:92-8
Martinez, Alexis N; Bluthenthal, Ricky N; Lorvick, Jennifer et al. (2007) The impact of legalizing syringe exchange programs on arrests among injection drug users in California. J Urban Health 84:423-35

Showing the most recent 10 out of 16 publications